{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Dianhydrogalactitol",
  "nciThesaurus": {
    "casRegistry": "23261-20-3",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A bifunctional hexitol derivative with potential antineoplastic activity. Dianhydrogalactitol alkylates and cross-links DNA via an epoxide group during all phases of the cell cycle, resulting in disruption of DNA function and cell cycle arrest.",
    "fdaUniiCode": "4S465RYF7M",
    "identifier": "C425",
    "preferredName": "Dianhydrogalactitol",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C475"
    ],
    "synonyms": [
      "1,2,5,6 dianhydrogalactitol",
      "1,2:5, 6-Dianhydrogalactitol",
      "1,2:5, 6-diepoxydulcitol",
      "1,2:5,6 dianhydrogalactitol",
      "1,2:5,6-Dianhydrodulcitol",
      "1,2:5,6-Diepoxydulcitol",
      "1,2:5,6-dianhydrodulcitol",
      "DAG",
      "DIANHYDROGALACTITOL",
      "Dianhydrodulcitol",
      "Dianhydrogalactitol",
      "Dulcitol diepoxide",
      "Galactitol",
      "Galactitol, 1,2:5,6-dianhydro- (8CI 9CI)",
      "dianhydrodulcitol",
      "diepoxydulcitol",
      "diepoxygalactitol",
      "dulcitol diepoxide",
      "galactitol, 1,2:5,6-dianhydro- (8CI 9CI)"
    ]
  }
}